No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
CNSP CNS Pharmaceuticals
- 0.1996
- -0.0081-3.90%
Close May 15 16:00 ET
2.12MMarket Cap-39P/E (TTM)
0.2130High0.1900Low188.00KVolume0.2076Open0.2077Pre Close37.63KTurnover2.10%Turnover RatioLossP/E (Static)10.63MShares2.980052wk High-0.48P/B1.79MFloat Cap0.190052wk Low--Dividend TTM8.95MShs Float170.6970Historical High--Div YieldTTM11.07%Amplitude0.1900Historical Low0.2000Avg Price1Lot Size
Pre-Market
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
CNS Pharmaceuticals | 10-Q: Quarterly report
CNS Pharmaceuticals Files for $75M Mixed Shelf Offering
12 Health Care Stocks Moving In Thursday's Pre-Market Session
GainersZai Lab (NASDAQ:ZLAB) stock increased by 21.5% to $20.14 during Thursday's pre-market session. The market value of their outstanding shares is at $1.9 billion. As per the news, the Q1 earnings
CNS Pharmaceuticals Enacts Key Corporate Governance Changes
CNS Pharmaceuticals to Participate in the Virtual Investor Lunch Break: The CNSP Opportunity
CNS Pharmaceuticals to Participate in the Virtual Investor Lunch Break: The CNSP Opportunity Download as PDF April 22, 2024 12:00am EDT Live video webcast with Chief Executive Officer, John Climaco,
CNS Pharmaceuticals Conducts Informational Investor Meetings
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg